Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK\/Egr-1 pathway - Wu_2023_FASEB.J_37_e22917 |
| Author(s) : Wu Q , Zhao M , Li D , He X , Zang W |
| Ref : FASEB Journal , 37 :e22917 , 2023 |
| Abstract : Wu_2023_FASEB.J_37_e22917 |
| ESTHER : Wu_2023_FASEB.J_37_e22917 |
| PubMedSearch : Wu_2023_FASEB.J_37_e22917 |
| PubMedID: 37039813 |
| Title : Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases - He_2015_Br.J.Pharmacol_172_5489 |
| Author(s) : He X , Zhao M , Bi X , Sun L , Yu X , Zang W |
| Ref : British Journal of Pharmacology , 172 :5489 , 2015 |
| Abstract : He_2015_Br.J.Pharmacol_172_5489 |
| ESTHER : He_2015_Br.J.Pharmacol_172_5489 |
| PubMedSearch : He_2015_Br.J.Pharmacol_172_5489 |
| PubMedID: 25378088 |
| Title : Pyridostigmine prevents peripheral vascular endothelial dysfunction in rats with myocardial infarction - Qin_2014_Clin.Exp.Pharmacol.Physiol_41_202 |
| Author(s) : Qin F , Lu Y , He X , Zhao M , Bi X , Yu X , Liu J , Zang W |
| Ref : Clinical & Experimental Pharmacology & Physiology , 41 :202 , 2014 |
| Abstract : Qin_2014_Clin.Exp.Pharmacol.Physiol_41_202 |
| ESTHER : Qin_2014_Clin.Exp.Pharmacol.Physiol_41_202 |
| PubMedSearch : Qin_2014_Clin.Exp.Pharmacol.Physiol_41_202 |
| PubMedID: 24471445 |